AbsEn.i
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « majority »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
major < majority < make  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000092 (2020) Camilla Br Dsgaard Nielsen [Danemark] ; Christian Nielsen [Danemark] ; Mads Nybo [Danemark] ; S Ren Andreas Just [Danemark] ; Pernille Just Vinholt [Danemark]The in vitro effect of antirheumatic drugs on platelet function.
000097 (2020) Weiyi Tan ; Jamil AboulhosnThe cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease
000273 (2020) Zheng Wang [États-Unis] ; Yicheng Zhao [États-Unis] ; Zhiqiang An [États-Unis] ; Wenliang Li [États-Unis]Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression
000279 (2020) Stefan Poschner ; Judith Wackerlig ; Dan Cacsire Castillo-Tong ; Andrea Wolf ; Isabel Von Der Decken ; Tea Lanišnik Rižner ; Renata Pavli ; Anastasia Meshcheryakova ; Diana Mechtcheriakova ; Monika Fritzer-Szekeres ; Theresia Thalhammer ; Walter J Ger [Autriche]Metabolism of Estrogens: Turnover Differs between Platinum-Sensitive and -Resistant High-Grade Serous Ovarian Cancer Cells
000286 (2020) Tiago Torres [Portugal] ; Luis Puig [Espagne]Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic
000299 (2020) Daniel H. Glaser [États-Unis] ; Christina Schutt [États-Unis] ; Kaila Schollaert-Fitch [États-Unis] ; Kathryn Torok [États-Unis]Linear Scleroderma of the Head - Updates in management of Parry Romberg Syndrome and En coup de sabre: A rapid scoping review across subspecialties
000320 (2020) Rachel A. O Eefe ; Neil E. Bhola ; David S. Lee ; Daniel E. Johnson ; Jennifer R. GrandisInterleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance
000340 (2020) Bong-Ha Shin [États-Unis] ; Matthew J. Everly [États-Unis] ; Hao Zhang [États-Unis] ; J. Choi [États-Unis] ; Ashley Vo [États-Unis] ; Xiaohai Zhang [États-Unis] ; Edmund Huang [États-Unis] ; Stanley C. Jordan [États-Unis] ; Mieko Toyoda [États-Unis]Impact of Tocilizumab (Anti-IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients With Chronic Antibody-mediated Rejection.
000412 (2020) Sathana Ingaralingam [Royaume-Uni] ; Saaeha Rauz [Royaume-Uni] ; Philip I. Murray [Royaume-Uni] ; Robert J. Barry [Royaume-Uni]Effectiveness of pharmacological agents for the treatment of non-infectious scleritis: a systematic review protocol
000451 (2020) Yue Zhang ; Qianhao Xu ; Zhuoyan Sun ; Lei ZhouCurrent targeted therapeutics against COVID-19: based on first-line experience in china
000563 (2020) Parth Shah ; Vinay Sundaram ; Einar BjörnssonBiologic and Checkpoint Inhibitor‐Induced Liver Injury: A Systematic Literature Review

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "majority" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "majority" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    majority
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021